All Pharma News
Transgene, NEC, and BostonGene Expand Collaboration

Transgene, NEC, and BostonGene Expand Collaboration
BUSINESSWIRE
05 Mar 2024
Share Share
Transgene Announces Upcoming Investor Meetings

Transgene Announces Upcoming Investor Meetings
BUSINESSWIRE
21 Dec 2023
Share Share
Transgene Strengthens its Leadership Team to Accelerate its Growth Strategy

Transgene Strengthens its Leadership Team to Accelerate its Growth Strategy
BUSINESSWIRE
05 Dec 2023
Share Share
Transgene Reports Business Update and Q3 2023 Financial Position

Transgene Reports Business Update and Q3 2023 Financial Position
BUSINESSWIRE
07 Nov 2023
Share Share
Transgene & BioInvent - First Patient Treated in Phase I Trial Assessing BT-001

Transgene & BioInvent - First Patient Treated in Phase I Trial Assessing BT-001
BUSINESSWIRE
10 Oct 2023
Share Share
Transgene Advances Its Innovative Immunotherapy Pipeline

Transgene Advances Its Innovative Immunotherapy Pipeline
BUSINESSWIRE
20 Sep 2023
Share Share
Transgene Announces Upcoming Investor Meetings

Transgene Announces Upcoming Investor Meetings
BUSINESSWIRE
14 Sep 2023
Share Share
Transgene and NEC Present New Data on TG4050

Transgene and NEC Present New Data on TG4050
BUSINESSWIRE
06 Jun 2023
Share Share
Transgene Presents Immunological Data Demonstrating that TG4001

Transgene Presents Immunological Data Demonstrating that TG4001
BUSINESSWIRE
05 Jun 2023
Share Share
Transgene and BioInvent report positive data for oncolytic virus

Transgene and BioInvent report positive data for oncolytic virus
CLINICAL TRIALS ARENA
25 May 2023
Share Share